Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Oric Pharmaceuticals	ORIC	22. nov 2024	9.59	+5.15
Oriental Culture	OCG	22. nov 2024	1.28	0.00
Oriental Rise Holdings	ORIS	22. nov 2024	6.15	0.00
Origin Agritech	SEED	22. nov 2024	2.45	-0.57
Origin Bancorp	OBK	22. nov 2024	35.02	+2.25
Origin Materials A	ORGN	22. nov 2024	1.24	+4.20
Orion Energy Systems	OESX	22. nov 2024	0.82	-1.98
Orion Group	ORN	22. nov 2024	8.55	-2.06
Orion Office REIT	ONL	22. nov 2024	4.07	+1.50
Orion S.A.	OEC	22. nov 2024	18.05	+0.28
Orix ADR	IX	22. nov 2024	107.62	-0.19
Orla Mining	ORLA	22. nov 2024	4.59	-0.22
Ormat Technologies	ORA	22. nov 2024	80.74	+0.82
Orrstown Financial Services	ORRF	22. nov 2024	40.49	+1.35
Orthofix Medical	OFIX	22. nov 2024	18.91	+1.23
OrthoPediatrics	KIDS	22. nov 2024	26.34	-0.49
Oruka Therapeutics	ORKA	22. nov 2024	20.75	0.00
OS Therapies	OSTX	22. nov 2024	1.95	+5.11
Oscar Health A	OSCR	22. nov 2024	15.98	-2.02
Oshkosh	OSK	22. nov 2024	111.81	+2.27
OSI Systems	OSIS	22. nov 2024	164.91	-0.25
Osisko Development	ODV	22. nov 2024	1.84	-3.16
Osisko Gold Royalties	OR	22. nov 2024	20.11	+1.26
Ostin Technology Group	OST	22. nov 2024	0.22	+0.46
Otis Worldwide	OTIS	22. nov 2024	101.20	+1.25
Otter Tail	OTTR	22. nov 2024	80.78	+0.25
Ouster	OUST	22. nov 2024	9.53	+6.24
Outbrain	OB	22. nov 2024	5.05	-0.98
Outfront Media	OUT	22. nov 2024	19.13	+1.00
Outlook Therapeutics	OTLK	22. nov 2024	5.03	-1.95

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.